research use only

Oxacillin sodium monohydrate Bacterial chemical

Name: Oxacillin sodium monohydrate
Brand: Selleck Chemicals
SKU: S2563
Availability: InStock
Rating: 5 (1 reviews)

Cat.No.S2563

Oxacillin sodium monohydrate (Methicillin) is an antibacterial agent and is a narrow spectrum beta-lactam antibiotic of the penicillin class.

Chemical Structure

Molecular Weight: 441.43

Jump to Mechanism of Action Solubility Chemical Information, Storage & Stability Specificity

Quality Control

Batch: Purity: 99.85%

99.85

Related Targets	Antibiotics Anti-infection Fungal Antiviral COVID-19 Parasite Reverse Transcriptase HIV HCV Protease SARS-CoV HIV Protease Influenza Virus β-lactamase Integrase HBV CMV Neuraminidase HCV HSV RSV Enterovirus Thioredoxin Reductase 3C-Like Protease Ribosomal Peptidyl Transferase HPV
Related Products	Berberine BTZ043 Racemate Teicoplanin Ornidazole Skatole Berberine Sulfate Pipemidic acid Ceftiofur PBTZ169 Aminothiazole Furagin Furaltadone HCl Nimorazole Trigonelline Hydrochloride Methyl α-D-mannopyranoside Artemisic acid Pefloxacin Mesylate Protionamide 6-Methoxydihydrosanguinarine

Chemical Information, Storage & Stability

Molecular Weight	441.43	Formula	C₁₉H₁₈N₃O₅S.Na.H₂O	Storage (From the date of receipt)	3 years-20°Cpowder
CAS No.	7240-38-2	Download SDF		Storage of Stock Solutions	1 year-80°Cin solvent 1 month-20°Cin solvent
Synonyms	Methicillin			Smiles	CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+]

Solubility

In vitro
Batch:

Water : 88 mg/mL

DMSO : Insoluble ( Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : Insoluble

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
=	×	×

Dilution Calculator Molecular Weight Calculator

In vivo Batch:
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT06282510	Recruiting	Candida Auris Infection\|Colonization Asymptomatic	Mary K Hayden\|Rush University Medical Center\|RML Specialty Hospital	January 29 2024	Phase 4
NCT05971550	Not yet recruiting	Neisseria Gonorrhoeae Infection\|Asymptomatic Pharyngeal Carriage	Assistance Publique - Hôpitaux de Paris	September 2023	Phase 3
NCT05100407	Completed	Multi-antibiotic Resistance	Kufa University	March 1 2022	--
NCT05197205	Unknown status	Sickle Cell Disease	Assistance Publique - Hôpitaux de Paris	February 1 2022	Not Applicable
NCT04597424	Active not recruiting	Unsafe Sex\|Risk-Taking	ANRS Emerging Infectious Diseases	January 19 2021	Phase 3
NCT03869437	Completed	Bloodstream Infections	The University of Queensland\|Shionogi	October 28 2019	Phase 2

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):